Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non–Small-Cell Lung Cancer: RTOG 0117

Similar Items

• A Phase I/II Radiation Dose Escalation Study with Concurrent Chemotherapy for Patients with Inoperable Stages I-III Non-Small Cell Lung Cancer: The Phase I Results of RTOG 0117
  od: Bradley, Jeffrey D., i dr.
  Izdano: (2010)
• Phase II Study of Accelerated High-Dose Radiation Therapy with Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer: RTOG 0239
  od: Komaki, Ritsuko, i dr.
  Izdano: (2012)
• A Phase II Comparative Study of Gross Tumor Volume Definition With or Without PET/CT Fusion in Dosimetric Planning for Non-Small Cell Lung Cancer (NSCLC): Primary Analysis of Radiation Therapy Oncology Group (RTOG) 0515
  od: Bradley, Jeffrey, i dr.
  Izdano: (2010)
• A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
  od: Zhao, Chuanhua, i dr.
  Izdano: (2016)
• Phase 2 Study of Pemetrexed plus Carboplatin, or Pemetrexed plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non-Small-Cell Lung Cancer
  od: Choy, Hak, i dr.
  Izdano: (2013)